Export Market Development Grant Scheme—2015 Review
The Export Council of Australia (ECA) welcomes the 2015 Review of the Export Market Development Grants (EMDG) scheme and is pleased to have the opportunity to put forward a submission to the reviewer, Mr Michael Lee.
The ECA understands that the purpose of this Review is to make recommendations about the future scope of the EMDG scheme. The ECA strongly supports the EMDG scheme, which since its introduction in 1974, has proven itself to be one of the most effective industry stimulus initiatives ever introduced by the Federal Government. The ECA (previously AIEx) is a long-time supporter of the scheme and has on numerous occasions provided submissions and evidence to government to support the scheme, especially given the positive impact EMDG has on Australian exporters.
The ECA, through the AIEx, was a major contributor to the last formal review of the scheme in 2008.
The ECA, therefore, rejects the recommendation of the 2014 Commission of Audit to discontinue the scheme and refers to the ECA’s 2013 and 2014 Trade Policy
Recommendations where its support and recommendations for the scheme are clearly articulated.

Join Us
Become A Member
Eric Meppem,
Co-Founder & Commercial Director,
Pharmako Biotechnologies Pty Ltd
Member of the ECA
"Pharmako Biotechnologies were already exporting when we joined the ECA. We joined to assist our export strategies, and unashamedly to promote ourselves
through the Australian Export Awards. As a small business, third party recognition and industry membership assist when dealing with large
multinational businesses."
Featured Member
Established in 1970, Mavlab Animal Health Pty Ltd is a Queensland based, family-owned, GMP licenced manufacturer of veterinary pharmaceuticals and pet care products. Mavlab has an extensive range of prescription and over the counter
products sold in a growing number of global markets. Contract manufacturing opportunities are also available.